Godrej Consumer Products Ltd Q4 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/l696w0dw9oczxsbr71byhk66.pdf

Key Takeaways


The RCCL Acquisition: Rationale & Structure

Sitapati: "See Vivek, one doesn't completely choose timings on things like this. But we felt confident when the opportunity came up that we were in the right direction in terms of market development of our core categories."

Cost Synergy Roadmap

Sitapati: "There is definitely a large scope to reduce MRP to NSV leakage and there are very simple things, for example, the urban distributors in RCCL makes 6.5% distributor margin, ours are at 5%. The rural channel there is a 10%, 11% distribution margin leave the retailers aside, ours is 7%. So, there are just very low hanging fruit."

Category Dynamics & Competitive Landscape

Sitapati: "I would say having done the analysis we are not worried. Along with the massive upside, which is if somebody can get this category right, and someone can convert Deodorants into Oral, in terms of being a regular use, hygiene product, from being as Nisa said a 'want' which you use when you go for a party... Then you have a really large TAM to play in."

Financial Roadmap: Margins, EPS & Funding


Strategic Context: Where This Fits in GCPL's Portfolio

Sitapati: "And if you look at the next decade or two decades the largest value creation opportunity for GCPL continue to be HI in India."

Guidance & Commitments

CommitmentSpecificsTimeline
Acquired business revenueFlat in absolute terms vs FY23FY24
Acquired business margins"Relatively better" than mid-to-high single digits, but not teensFY24
EPS impactDilutiveFY24
EPS impactLargely neutralFY25
Acquired business growthLow double-digits to mid-teensFY25 onwards
Acquired business EBITDA marginMid-20sFY25 onwards
Balance sheetReturn to net cashMid-FY24
SKU rationalizationRemove non-core, low-margin SKUsYear one (FY24)
Distribution ramp-upLeverage GCPL's 4x reach for Park AvenueTo begin immediately, gains not in first few months

Key Metrics

MetricQ4 FY23
Revenue (RCCL acquired business)~₹620 cr (FY23)
EBITDA margin (RCCL)Mid to high single digits (FY23)
Revenue growth guidance (RCCL)Flattish in absolute terms (FY24 vs FY23)
EBITDA margin guidance (RCCL)Relatively better than FY23, but not teens (FY24)
Revenue growth ambition (RCCL)Low double digits to mid-teens (from FY25 onwards)
EBITDA margin ambition (RCCL)Mid-20s (from FY25 onwards)
EPS impact of acquisitionDilutive (FY24), largely neutral (FY25)
Gross valuation of acquisition₹2,825 cr
Net valuation of acquisition~₹2,725 cr
Net valuation adjusted for cash tax savings~₹2,325 cr, implies ~3.7 to 3.8x FY23 sale value
Deodorants market share (Park Avenue)#2 in men's, rock-steady at 18% to 19%
Condoms market share (Kamasutra)#3 in commercial condoms
Deodorants market size (India)~₹5,000 cr
Commercial condoms market size (India)~₹1,200 cr
Deodorants per capita consumption (India)~40 cents